ABO-话题@MedSci

#ABO#

270篇内容 | 2100人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1598156, encodeId=427c1598156fc, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabolism：100年后，科学家发现了胰岛素之外的第二个血糖调控通路，打开糖尿病治疗新大门, objectType=article, longId=293504, objectId=1f94293504ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f94293504ff, replyNumber=0, likeNumber=17, createdTime=2022-01-07, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f94293504ff, moduleTitle=Cell Metabolism：100年后，科学家发现了胰岛素之外的第二个血糖调控通路，打开糖尿病治疗新大门, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f94293504ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598155, encodeId=2ca015981550c, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！, objectType=article, longId=292783, objectId=80f3292e835e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80f3292e835e, replyNumber=0, likeNumber=33, createdTime=2021-12-28, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f3292e835e, moduleTitle=Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80f3292e835e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598154, encodeId=6916159815431, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=美国批准长效药物Apreude（cabotegravir）用于HIV暴露前预防, objectType=article, longId=292580, objectId=21ce29258046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21ce29258046, replyNumber=0, likeNumber=0, createdTime=2021-12-24, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21ce29258046, moduleTitle=美国批准长效药物Apreude（cabotegravir）用于HIV暴露前预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21ce29258046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598152, encodeId=f6b6159815205, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=内分泌期刊推荐：Therapeutic Advances in Endocrinology and Metabolism, objectType=article, longId=292186, objectId=f648292186ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f648292186ca, replyNumber=0, likeNumber=19, createdTime=2021-12-19, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f648292186ca, moduleTitle=内分泌期刊推荐：Therapeutic Advances in Endocrinology and Metabolism, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f648292186ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598153, encodeId=06581598153ac, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Clin Cancer Res：Cabozantinib（卡博替尼）单药治疗难治性软组织肉瘤(STS)的疗效和安全性, objectType=article, longId=291974, objectId=52c52919e488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52c52919e488, replyNumber=0, likeNumber=62, createdTime=2021-12-18, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52c52919e488, moduleTitle=Clin Cancer Res：Cabozantinib（卡博替尼）单药治疗难治性软组织肉瘤(STS)的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52c52919e488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598159, encodeId=9cf2159815907, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Nature Metabolism：中科院孙宇团队发现，葡萄籽提取物有抗衰老潜力, objectType=article, longId=291801, objectId=333b29180191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=333b29180191, replyNumber=0, likeNumber=38, createdTime=2021-12-15, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=333b29180191, moduleTitle=Nature Metabolism：中科院孙宇团队发现，葡萄籽提取物有抗衰老潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=333b29180191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598151, encodeId=eefa15981513f, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL, objectType=article, longId=221546, objectId=86b522154637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86b522154637, replyNumber=0, likeNumber=18, createdTime=2021-12-06, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86b522154637, moduleTitle=Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86b522154637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598150, encodeId=4b51159815044, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer, objectType=article, longId=221045, objectId=9e8a22104543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8a22104543, replyNumber=0, likeNumber=27, createdTime=2021-11-27, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8a22104543, moduleTitle=Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8a22104543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598149, encodeId=b3951598149af, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！, objectType=article, longId=221005, objectId=ce16221005d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce16221005d3, replyNumber=0, likeNumber=42, createdTime=2021-11-26, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce16221005d3, moduleTitle=Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce16221005d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598148, encodeId=e45c159814841, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle= 【文献解读】将美延续，一款强大且更为长效的抗衰肉毒素“AboBoNT-A” , objectType=article, longId=220971, objectId=e6ad2209e11b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6ad2209e11b, replyNumber=0, likeNumber=39, createdTime=2021-11-26, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6ad2209e11b, moduleTitle= 【文献解读】将美延续，一款强大且更为长效的抗衰肉毒素“AboBoNT-A” , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6ad2209e11b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598147, encodeId=7700159814e80, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabolism：要想抗衰老，先得吃得好：在抗衰老和代谢健康方面，饮食胜过“神药”, objectType=article, longId=220844, objectId=163122084484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=163122084484, replyNumber=0, likeNumber=35, createdTime=2021-11-24, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=163122084484, moduleTitle=Cell Metabolism：要想抗衰老，先得吃得好：在抗衰老和代谢健康方面，饮食胜过“神药”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=163122084484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598146, encodeId=3c28159814694, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Liver Cancer：卡博替尼（Cabozantinib）治疗晚期肝癌的疗效和安全性：来自国际多中心真实世界研究, objectType=article, longId=220567, objectId=10c022056e58, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10c022056e58, replyNumber=0, likeNumber=38, createdTime=2021-11-20, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10c022056e58, moduleTitle=Liver Cancer：卡博替尼（Cabozantinib）治疗晚期肝癌的疗效和安全性：来自国际多中心真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10c022056e58)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598145, encodeId=86f015981457c, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle= 【文献解读】有了OnaBoNT-A为何还要AboBoNT-A？, objectType=article, longId=219791, objectId=f107219e9103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f107219e9103, replyNumber=0, likeNumber=50, createdTime=2021-11-06, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f107219e9103, moduleTitle= 【文献解读】有了OnaBoNT-A为何还要AboBoNT-A？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f107219e9103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598144, encodeId=06c1159814464, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Nature Metabolism：味精导致肥胖？研究揭示味精诱导肥胖的具体机制, objectType=article, longId=219368, objectId=640321936859, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=640321936859, replyNumber=0, likeNumber=37, createdTime=2021-10-29, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=640321936859, moduleTitle=Nature Metabolism：味精导致肥胖？研究揭示味精诱导肥胖的具体机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=640321936859)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598143, encodeId=49e9159814326, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=The Oncologist：PPIs的联合使用对Cabozantinib（卡博替尼）治疗转移性肾细胞癌(mRCC)的影响, objectType=article, longId=219184, objectId=9df12191846b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9df12191846b, replyNumber=0, likeNumber=39, createdTime=2021-10-26, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9df12191846b, moduleTitle=The Oncologist：PPIs的联合使用对Cabozantinib（卡博替尼）治疗转移性肾细胞癌(mRCC)的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9df12191846b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598142, encodeId=614c15981426c, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Eur J Cancer: 卡博替尼（Cabozantinib）治疗转移性肾细胞癌的疗效：来自真实世界研究CABOREAL结果分析, objectType=article, longId=219150, objectId=a7ac21915026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7ac21915026, replyNumber=0, likeNumber=33, createdTime=2021-10-25, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7ac21915026, moduleTitle=Eur J Cancer: 卡博替尼（Cabozantinib）治疗转移性肾细胞癌的疗效：来自真实世界研究CABOREAL结果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7ac21915026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598141, encodeId=94b31598141c3, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Metabolism：三羧酸循环相关代谢物与房颤和心衰风险的关系, objectType=article, longId=218940, objectId=6467218940c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6467218940c2, replyNumber=0, likeNumber=43, createdTime=2021-10-22, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6467218940c2, moduleTitle=Metabolism：三羧酸循环相关代谢物与房颤和心衰风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6467218940c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598140, encodeId=27a8159814047, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Metabolism：亚洲非肥胖非酒精性脂肪肝流行病学数据, objectType=article, longId=218757, objectId=2bc3218e5757, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bc3218e5757, replyNumber=0, likeNumber=37, createdTime=2021-10-19, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bc3218e5757, moduleTitle=Metabolism：亚洲非肥胖非酒精性脂肪肝流行病学数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bc3218e5757)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598139, encodeId=75681598139cd, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=苏格兰药物联盟 (SMC) 批准Cabometyx/Opdivo组合治疗晚期肾癌患者, objectType=article, longId=218568, objectId=c15d218568ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15d218568ba, replyNumber=0, likeNumber=44, createdTime=2021-10-16, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15d218568ba, moduleTitle=苏格兰药物联盟 (SMC) 批准Cabometyx/Opdivo组合治疗晚期肾癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c15d218568ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598138, encodeId=7665159813847, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle= 【文献解读】一种起效更快、持续时间更长的A型肉毒毒素——“AboBoNT-A” , objectType=article, longId=218528, objectId=87bd218528dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87bd218528dd, replyNumber=0, likeNumber=0, createdTime=2021-10-15, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87bd218528dd, moduleTitle= 【文献解读】一种起效更快、持续时间更长的A型肉毒毒素——“AboBoNT-A” , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87bd218528dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ABO

2020-05-29

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabolism：100年后，科学家发现了胰岛素之外的第二个血糖调控通路，打开糖尿病治疗新大门

2022-01-07

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！

2021-12-28

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

美国批准长效药物Apreude（cabotegravir）用于HIV暴露前预防

2021-12-24

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

内分泌期刊推荐：Therapeutic Advances in Endocrinology and Metabolism

2021-12-19

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Clin Cancer Res：Cabozantinib（卡博替尼）单药治疗难治性软组织肉瘤(STS)的疗效和安全性

2021-12-18

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Nature Metabolism：中科院孙宇团队发现，葡萄籽提取物有抗衰老潜力

2021-12-15

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL

2021-12-06

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer

2021-11-27

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！

2021-11-26

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

【文献解读】将美延续，一款强大且更为长效的抗衰肉毒素“AboBoNT-A”

2021-11-26

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabolism：要想抗衰老，先得吃得好：在抗衰老和代谢健康方面，饮食胜过“神药”

2021-11-24

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Liver Cancer：卡博替尼（Cabozantinib）治疗晚期肝癌的疗效和安全性：来自国际多中心真实世界研究

2021-11-20

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

【文献解读】有了OnaBoNT-A为何还要AboBoNT-A？

2021-11-06

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Nature Metabolism：味精导致肥胖？研究揭示味精诱导肥胖的具体机制

2021-10-29

zhouqu_8 (审核中...)

前往app查看评论内容

#ABO#

The Oncologist：PPIs的联合使用对Cabozantinib（卡博替尼）治疗转移性肾细胞癌(mRCC)的影响

2021-10-26

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Eur J Cancer: 卡博替尼（Cabozantinib）治疗转移性肾细胞癌的疗效：来自真实世界研究CABOREAL结果分析

2021-10-25

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Metabolism：三羧酸循环相关代谢物与房颤和心衰风险的关系

2021-10-22

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Metabolism：亚洲非肥胖非酒精性脂肪肝流行病学数据

2021-10-19

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

苏格兰药物联盟 (SMC) 批准Cabometyx/Opdivo组合治疗晚期肾癌患者

2021-10-16

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

【文献解读】一种起效更快、持续时间更长的A型肉毒毒素——“AboBoNT-A”

2021-10-15

科室
- - 订阅+
  - 更多科室
工具
服务